Article info
PDFLetter
Low skeletal muscle mass is clinically underestimated in advanced metastatic prostate cancer: the cross-sectional SCAN study
- Correspondence to Dr Mario Di Palma; mario.dipalma{at}gustaveroussy.fr
Citation
Low skeletal muscle mass is clinically underestimated in advanced metastatic prostate cancer: the cross-sectional SCAN study
Publication history
- Received July 8, 2022
- Accepted August 22, 2022
- First published September 13, 2022.
Online issue publication
December 25, 2024
Article Versions
- Previous version (13 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.